INS and type 1 diabetes mellitus: Ideally, the candidates for such trials should be patients with type 1 diabetes, who have tried all strategies to attain good metabolic control with acceptable rates of hypoglycemia, including frequent glucose monitoring, adjusting insulin dosages according to changes in meals and exercise, and who have been followed closely by a healthcare team.